ACEN President Warns -Nigeria Faces Drug Access Crisis for Diabetes, Endocrine Conditions

Nigeria is grappling with a growing crisis in access to essential medicines for diabetes and other endocrine-related conditions, according to the President of the Association of Clinical Endocrinologists of Nigeria (ACEN). The warning highlights deepening concerns within the healthcare sector about the availability, affordability, and distribution of life-saving drugs for millions of patients nationwide.

Rising Burden, Shrinking Access

Healthcare experts say the burden of diabetes and endocrine disorders is increasing steadily across Nigeria, driven by lifestyle changes, urbanisation, and limited preventive care. Despite this rise, access to critical medications—such as insulin and hormone therapies—remains inconsistent, leaving many patients vulnerable to complications.

Medical professionals note that the cost of treatment has surged in recent years, largely due to currency fluctuations, import dependency, and supply chain disruptions. For many patients, particularly those in low-income brackets, the financial strain has made consistent treatment nearly impossible, leading to skipped doses or complete discontinuation of care.

The ACEN President emphasised that without urgent intervention, the country could face a surge in preventable complications such as kidney failure, blindness, and cardiovascular diseases, all of which place additional pressure on an already strained healthcare system.

Systemic Challenges in Supply and Policy

Stakeholders and ACEN as a professional body point to structural weaknesses in Nigeria’s pharmaceutical supply chain as a key driver of the crisis. Heavy reliance on imported drugs exposes the system to global market shocks, while limited local production capacity constrains the ability to respond effectively to shortages.

In addition, regulatory bottlenecks and inefficiencies in distribution networks have compounded the problem. Rural and underserved communities are particularly affected, where access to specialised care and essential medicines is often limited or non-existent.

ACEN and Experts are calling for policy reforms that prioritise local drug manufacturing, streamline import processes, and improve healthcare financing. Expanding health insurance coverage and subsidising essential medications are also seen as critical steps toward easing the burden on patients.

Calls for Urgent Intervention

The ACEN leadership has urged the federal government, private sector stakeholders, and international partners to take coordinated action. Recommendations include strengthening public-private partnerships, investing in local pharmaceutical infrastructure, and ensuring price regulation mechanisms to prevent excessive markups.

Healthcare advocates also stress the importance of ACEN awareness campaigns and early diagnosis initiatives to reduce long-term complications. By improving access to testing and treatment at the primary healthcare level, experts believe outcomes for patients can be significantly improved.

Ultimately, the crisis underscores the need for a comprehensive and sustainable healthcare strategy that addresses both immediate drug shortages and the broader systemic issues affecting Nigeria’s health sector.